Exercise as Treatment for "Stress-Related" Mental Disorders
This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The ...
Source: Current Neuropharmacology - October 2, 2023 Category: Drugs & Pharmacology Authors: Antonia Bendau Moritz Bruno Petzold Jan Kaminski Jens Plag Andreas Str öhle Source Type: research

Exercise as Treatment for "Stress-Related" Mental Disorders
This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The ...
Source: Current Neuropharmacology - October 2, 2023 Category: Drugs & Pharmacology Authors: Antonia Bendau Moritz Bruno Petzold Jan Kaminski Jens Plag Andreas Str öhle Source Type: research

Exercise as Treatment for "Stress-Related" Mental Disorders
This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The ...
Source: Current Neuropharmacology - October 2, 2023 Category: Drugs & Pharmacology Authors: Antonia Bendau Moritz Bruno Petzold Jan Kaminski Jens Plag Andreas Str öhle Source Type: research

Exercise as Treatment for "Stress-Related" Mental Disorders
This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The ...
Source: Current Neuropharmacology - October 2, 2023 Category: Drugs & Pharmacology Authors: Antonia Bendau Moritz Bruno Petzold Jan Kaminski Jens Plag Andreas Str öhle Source Type: research

Exercise as Treatment for "Stress-Related" Mental Disorders
This article aims to provide a concise overview of essential evidence regarding the effectiveness and underlying mechanisms of physical activity for individuals with mental disorders clustered as "stress-related" conditions. Empirical findings (e.g., longitudinalprospective studies, interventional randomized-controlled-trials, reviews, meta-analyses) regarding the effects of physical activity in the prevention and treatment of stress-related mental disorders are summarized. Furthermore, potential mechanisms underlying these effects are discussed, and recommendations regarding the use of physical activity are outlined. The ...
Source: Current Neuropharmacology - October 2, 2023 Category: Drugs & Pharmacology Authors: Antonia Bendau Moritz Bruno Petzold Jan Kaminski Jens Plag Andreas Str öhle Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Is Pain a Symptom or a Disease? How Does the New Evidence Help to Better Understand this Unsolved Question?
Curr Neuropharmacol. 2023 Sep 21. doi: 10.2174/1570159X2201230921165106. Online ahead of print.NO ABSTRACTPMID:37735864 | DOI:10.2174/1570159X2201230921165106 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 22, 2023 Category: Drugs & Pharmacology Authors: Massimo Allegri Source Type: research

Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
CONCLUSION: Our findings highlight a previously unknown cohesive picture of the glutamatergic implications of LiCl action that persist long after the end of its administration, revealing for the first time a profound and persistent reorganization of the glutamatergic postsynaptic density receptor composition and structure.PMID:37711124 | DOI:10.2174/1570159X21666230913144420 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 15, 2023 Category: Drugs & Pharmacology Authors: Lucia Caffino Giorgia Targa Anne Stephanie Mallien Francesca Mottarlini Beatrice Rizzi Judith R Homberg Peter Gass Fabio Fumagalli Source Type: research

Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial
CONCLUSION: This study demonstrates that low-dose OLA in combination with sertraline had clinically meaningful improvements not only in the negative and depressive symptoms but also in psychosocial functioning in patients with FE-SCH, while not affecting positive symptoms.PMID:37711125 | DOI:10.2174/1570159X21666230913152344 (Source: Current Neuropharmacology)
Source: Current Neuropharmacology - September 15, 2023 Category: Drugs & Pharmacology Authors: Meihong Xiu Lei Zhao Qianqian Sun Xiaoe Lang Source Type: research